Melanoma Cell

Harnessing the potential of radiation treatment of brain metastases to improve melanoma immunotherapy
Corey D McNeilly, Lukas W Pfannenstiel, Chaomei Xiang, Jennifer Yu, Brian R Gastman

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P367; DOI: 10.1186/2051-1426-3-S2-P367
Interaction between effector and memory cd8+ t cells enhances melanoma adoptive immunotherapy
Amanda Contreras, Andrew Tatar, Siddhartha Sen, Justin Meyers, Prakrithi Srinand, David Mahvi, Clifford Cho

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P8; DOI: 10.1186/2051-1426-3-S2-P8
Alternate antigen processing in the presence of gamma interferon may misdirect the immune recognition of cancer
Katherine Woods, Ralf B Schittenhelm, Dani Heesterbeek, Ashley Knights, Matthew Anaka, Anthony W Purcell, Andreas Behren, Jonathan Cebon

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P453; DOI: 10.1186/2051-1426-3-S2-P453
ImmTACs: bi-specific TCR-anti-CD3 fusions for targeted tumour killing
Zoe Donnellan, Giovanna Bossi, Jane Harper, Joseph Dukes, Nathaniel Liddy, Samantha Paston, Tara Mahon, Peter Molloy, Malkit Sami, Emma Baston, Brian Cameron, Andrew Johnson, Annelise Vuidepot, Namir Hassan, Bent Jakobsen

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P299; DOI: 10.1186/2051-1426-3-S2-P299
Betulin - a plant-derived cytostatic drug - enhances antitumor immune response
Kathrin Pfarr, Corina Danciu, Cristina Dehelean, Josef M Pfeilschifter, Heinfried H Radeke

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P175; DOI: 10.1186/2051-1426-2-S3-P175
GIFT4-augmented B cells for melanoma immunotherapy
Jiusheng Deng, Andrea Pennati, Shala Yuan, Ragini Kudchadkar, David Lawson, Jacques Galipeau

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P9; DOI: 10.1186/2051-1426-2-S3-P9
TLR2/6 agonists and IFN-gamma treatment induces favorable immune cell recruiting signatures from melanoma associated with STAT1 and IL-32 signaling
Ileana S Mauldin, Craig L Slingluff, Ena Wang

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P225; DOI: 10.1186/2051-1426-2-S3-P225
Blockade of Treg derived TGF-β abrogates suppression of effector T cell function within the tumor microenvironment
Sadna Budhu, David Schaer, Yongbiao Li, Alan Houghton, Samuel Silverstein, Taha Merghoub, Jedd Wolchok

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P173; DOI: 10.1186/2051-1426-1-S1-P173
TLR2/6 agonists and IFNγ synergize to induce melanoma cells to produce T-cell recruiting chemokines
Ileana S Mauldin, Ena Wang, Donna H Deacon, Craig L Slingluff

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) O17; DOI: 10.1186/2051-1426-1-S1-O17

Log in using your username and password

Main menu

Log in using your username and password

You are here

Melanoma Cell